Composition for treatment of CXCL8-mediated lung inflammation

Details for Australian Patent Application No. 2010294225 (hide)

Owner Protaffin Biotechnologie AG

Inventors Kungl, Andreas; Slingsby, Jason; Adage, Tiziana; Rek, Angelika

Agent TJIP Patents Trade Marks & Designs

Pub. Number AU-A-2010294225

PCT Pub. Number WO2011/029931

Priority 61/241,771 11.09.09 US; 10155086.1 01.03.10 EP; 09175203.0 06.11.09 EP

Filing date 13 September 2010

Wipo publication date 17 March 2011

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/029931 Priority application(s): WO2011/029931

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010294240-PlGF-1 in homodimeric form

2010294214-Heterocylcic derivatives as inhibitors of glutaminyl cyclase